Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma
Clinical trial NCT06952621 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06952621
- Sponsor
- Tang-Du Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-12-28
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.